Epoprostenol: A Look at a Last-Line Inhalation Therapy for ARDS

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Justin Reinert, PharmD

Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by the rapid onset of widespread inflammation in the lungs, but inhaled epoprostenol can be used as a last-line treatment strategy for these patients. Learn more about this treatment option’s efficacy and safety with Dr. Charles Turck and Dr. Justin Reinert, Assistant Professor of Clinical Pharmacy at the University of Toledo.